Skip to main content
Premium Trial:

Request an Annual Quote

GenoMed Set to List on Nasdaq OTC in Early 03

NEW YORK, Nov. 8 - Look for GenoMed to be listed on Nasdaq's over-the-counter exchange sometime in early 2003.

 

The St. Louis-based company today said the Securities and Exchange Commission has "verbally provided" it with a thumb's up. GenoMed currently appears on the Pink Sheet's OTC and will retain its GMED ticker symbol, a company spokeswoman said.